Bausch + Lomb completes acquisition of Technolas

ROCHESTER, NY -- Global eye health company Bausch + Lomb said it has completed its acquisition of Technolas Perfect Vision GmbH, a leading ophthalmology laser company based in Munich. The new entity will be known as Bausch + Lomb Technolas, with a continued commitment to the development and commercialization of surgical laser technology in the ophthalmic field.

Bausch + Lomb originally announced its intent to purchase all outstanding and unowned shares of Technolas Perfect Vision in November 2012. Technolas Perfect Vision was established in 2009 through a joint venture between Bausch + Lomb and 20/10 PERFECT VISION AG to develop and sell advanced refractive and cataract technologies. Financial details of the acquisition are not being disclosed.

The Technolas Perfect Vision team will become part of Bausch + Lomb's Surgical business, and their femtosecond and excimer laser platforms for cataract and refractive surgery will broaden the company's already robust product portfolio and new product pipeline.

Since December 2011, the two companies have been co-promoting the VICTUS femtosecond laser, which can perform both cataract and refractive procedures on a single platform. The VICTUS platform received marketing approval from regulatory authorities in Europe in late 2011 and received key clearances from the U.S. Food and Drug Administration (FDA) in July 2012. In addition to the VICTUS platform, Technolas is developing excimer lasers for advanced refractive procedures and in the European Union is commercializing SUPRACOR, a new technology for the treatment of presbyopia.

Kristian Hohla, Ph.D., chief executive officer of Technolas Perfect Vision, will serve as the president of Bausch + Lomb Technolas, reporting to John Barr, executive vice president and president, Bausch + Lomb Global Surgical.